A 23% plunge in ARS Pharmaceuticals stock followed the June 24, 2026, disclosure that the company’s drug, Neffy®, failed to secure any new commercial formulary additions during the July review cycle. The sharp market correction triggered a securities fraud investigation by law firm Levi & Korsinsky into the company’s prior commercial growth forecasts.
Shareholders of Badger Meter, Inc. are facing a potential recovery window following the filing of a class action lawsuit alleging the company misled the market. The litigation centers on claims that the firm misrepresented its financial health by pulling customer orders forward to bolster its public performance metrics.
A sharp 13–17% collapse in Hyliion Holdings' share price has triggered a formal investigation by the law firm Levi & Korsinsky. The slide followed a report from Pelican Way Research that questioned the legitimacy of a $133 million deal, which had previously served as a primary catalyst for the company's recent market rally.
Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, are being urged to join a class action lawsuit. The litigation claims the medical device company issued false fiscal projections while concealing significant operational hurdles within its core pen needle market.
As the USTR Section 301 investigation panel begins hearings on Brazil today, the advocacy group Consumer Action for a Strong Economy (CASE) is lobbying the Trump administration to reject proposed tariffs on lean beef imports, warning that such measures function as a direct tax on American household grocery bills.
Navigating the complexities of property protection requires more than just a standard policy. With Arizona-specific risks like monsoon winds and flash flooding, understanding the nuances of dwelling, liability, and personal property coverage is essential for homeowners looking to secure their financial stability against unexpected accidents and structural damage.
Investors who purchased Embecta Corp. securities between November 25, 2025, and May 4, 2026, face an August 17, 2026, deadline to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging that the company issued misleading fiscal guidance while concealing significant market headwinds.
The traditional "wait and see" approach to glaucoma and cataract care is fading in favor of proactive intervention. Dr. I. Paul Singh and Dr. R. Krishna Sanka of the Eye Centers of Racine and Kenosha argue that addressing ocular pressure and lens degradation early prevents permanent vision loss and enhances patient quality of life.
Investors who held Futu Holdings Limited stock between May 2023 and May 2026 are facing a potential recovery window following a class action lawsuit. The litigation targets the company for allegedly misleading shareholders regarding its compliance with Chinese regulatory licensing requirements.
Shareholders who purchased Futu Holdings Limited stock between May 24, 2023, and May 27, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is seeking investors who suffered financial losses due to the company’s alleged failure to maintain compliance with Chinese regulatory mandates.
Investors who purchased Peabody Energy Corporation securities between October 14, 2024, and May 4, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is seeking participants to allege that the coal producer misled the market regarding the operational viability of its Centurion mine.
Investors who purchased Peabody Energy stock between October 14, 2024, and May 4, 2026, are facing a legal deadline as a class action lawsuit accuses the company of misleading the market regarding production growth at its Centurion mine.
Investors who purchased ZoomInfo Technologies stock between November 3, 2025, and May 11, 2026, face a critical deadline as a class action lawsuit moves forward. The litigation centers on allegations that the company misled shareholders regarding the market demand for its AI-powered product suite.
The European Commission has authorized TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma. This approval marks the first bispecific-based, chemotherapy-free treatment option in Europe for patients requiring second-line therapy, offering a new path to durable remission.
The European Commission has authorized the use of TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma, marking the first time a chemotherapy-free, bispecific-based therapy has been approved for this condition in a second-line setting across Europe.
Hong Kong-based software developer iToolab has updated its WatsGo platform to allow users to restore WhatsApp data directly from iCloud without resetting their iPhones. The feature bypasses the standard requirement to uninstall and reinstall the application, streamlining the recovery of chats, photos, and videos for mobile users.
Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, face a July 27 deadline to join a class action lawsuit. The litigation alleges that the company violated federal securities laws by issuing false statements regarding the performance of its core product lines, including Librela, Apoquel, and Cytopoint.
Investors who held Hub Group, Inc. stock between April 28, 2023, and May 11, 2026, are being urged to evaluate their legal options. The DJS Law Group has initiated a class action lawsuit against the transportation management company, alleging that inaccurate financial disclosures misled shareholders for over three years.
Investors who purchased Zoetis Inc. securities between January 14, 2025, and May 6, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation centers on allegations that the pharmaceutical company provided false information regarding its veterinary medication performance.
Investors who purchased Hub Group securities between April 28, 2023, and May 11, 2026, are being urged to join a class action lawsuit against the logistics firm. The Schall Law Firm alleges that the company issued false financial statements, leading to significant shareholder losses once the discrepancies became public knowledge.
Investors who purchased ADMA Biologics stock between August 9, 2024, and March 25, 2026, face a critical August 10 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders by concealing related-party transactions and inflating sales figures through aggressive channel stuffing.
Investors who purchased ADMA Biologics, Inc. securities between August 9, 2024, and March 25, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders through undisclosed related-party transactions and revenue manipulation, causing significant financial damages once the truth surfaced.
With feline adoptions outpacing dogs, Tevra Brands is betting on a new delivery method for pet wellness. The company’s Vetality Brush Free Twist + Lick Dental Gel ditches the toothbrush, utilizing a catnip-flavored formula that owners dispense directly to their pets to combat plaque and tartar buildup.
A $42.5 million recovery for a fatal petrochemical plant accident has vaulted Houston-based Armstrong Lee & Baker LLP to the top of the 2025 Texas rankings. The firm earned the number one spot from TopVerdict.com across six distinct workplace injury categories, highlighting a major victory in industrial litigation.
Surplus Solutions, a portfolio company backed by NMS Capital, has acquired Frederick-based DCM BioServices to bolster its technical maintenance and laboratory automation capabilities. The deal unites Surplus Solutions’ equipment lifecycle management platform with DCM Bio’s established service network, though specific financial terms of the transaction remain undisclosed.
Two back-to-back short-seller reports have triggered a formal investigation into Blaize Holdings, Inc. as shareholders face significant losses. The legal firm Johnson Fistel, PLLP is currently reviewing potential claims under federal securities laws to determine if the company misled investors regarding its business dealings and revenue projections.
The ninth annual National Prosecco Week concluded on June 21, 2026, marking a significant expansion for the Italian consortium across the United States. Through a blend of retail partnerships, high-profile culinary festival activations, and a national cocktail competition, the campaign emphasized the brand's integration into American lifestyle and dining culture.
Small businesses selling used electronics can now access professional-grade diagnostic and data erasure tools at no cost. CypherBlk, powered by Apkudo, launched PhoneShield to bridge the trust gap between independent refurbishers and enterprise-level operations, providing free software access to qualifying shops with fewer than 150 employees.
With $14 million in new Series A funding, Helsinki-based CurifyLabs is betting that 3D printing can modernize the slow, manual world of pharmacy compounding. The round, co-led by Sandwater and HealthCap, provides the capital necessary to accelerate U.S. expansion and ramp up the production of its automated medication systems.
A 24% single-day stock collapse followed by a further 26% decline has triggered a formal investigation into Simulations Plus, Inc. The law firm Johnson Fistel, PLLP is currently probing whether the company misled investors regarding its fiscal health and internal accounting controls prior to a massive revenue guidance downgrade.
